iTeos Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
iTeos Therapeutics is a clinical-stage biotechnology research company focused on immuno-oncology. It seeks to discover and develop immuno-oncology therapeutics by applying knowledge of tumor immunology and immunosuppressive pathways to restore the immune response against cancer. Its pipeline comprises three clinical-stage programs targeting immuno-oncology pathways, including the TIGIT/CD226 axis and the adenosine pathway, with optimized pharmacologic properties. The company has 11-50 employees and lists an address at 139 Main Street, Cambridge, Massachusetts; it is described as headquartered in Watertown, Massachusetts with a research center in Gosselies, Belgium. This information reflects its organizational scope and geographic footprint as provided.